HCW Biologics annual depreciation and amortization
2020
2021
2022
2023
2024
2025
HCW Biologics Depreciation & Amortization Growth & History (HCWB)
HCW Biologics's depreciation and amortization was $1.0M for fiscal 2025.
View full HCW Biologics company overviewHCW Biologics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.0M | −$142,618 | −12.04% |
| 2024 | 2024-12-31 | $1.2M | $49,205 | +4.33% |
| 2023 | 2023-12-31 | $1.1M | $417,330 | +58.14% |
| 2022 | 2022-12-31 | $717,854 | $174,256 | +32.06% |
| 2021 | 2021-12-31 | $543,598 | −$29,270 | −5.11% |
| 2020 | 2020-12-31 | $572,868 | — | — |
HCW Biologics quarterly depreciation and amortization
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $127,095 | −$164,821 | −56.46% |
| Q1 2026 | 2026-03-31 | $142,049 | −$276,961 | −66.10% |
| Q4 2025 | 2025-12-31 | $156,940 | — | — |
| Q3 2025 | 2025-09-30 | $173,905 | $45,456 | +35.39% |
| Q2 2025 | 2025-06-30 | $291,916 | $161,984 | +124.67% |
| Q1 2025 | 2025-03-31 | $419,010 | $175,509 | +72.08% |
| Q3 2024 | 2024-09-30 | $128,449 | −$149,005 | −53.70% |
| Q2 2024 | 2024-06-30 | $129,932 | −$154,401 | −54.30% |
| Q1 2024 | 2024-03-31 | $243,501 | −$55,346 | −18.52% |
| Q3 2023 | 2023-09-30 | $277,454 | $113,121 | +68.84% |
| Q2 2023 | 2023-06-30 | $284,333 | $134,755 | +90.09% |
| Q1 2023 | 2023-03-31 | $298,847 | $156,062 | +109.30% |
| Q3 2022 | 2022-09-30 | $164,333 | $41,877 | +34.20% |
| Q2 2022 | 2022-06-30 | $149,578 | −$5,295 | −3.42% |
| Q1 2022 | 2022-03-31 | $142,785 | −$16,021 | −10.09% |
| Q3 2021 | 2021-09-30 | $122,456 | −$3,758 | −2.98% |
| Q2 2021 | 2021-06-30 | $154,873 | — | — |
| Q1 2021 | 2021-03-31 | $158,806 | — | — |
| Q3 2020 | 2020-09-30 | $126,214 | — | — |
HCW Biologics depreciation and amortization trends
Over the last five fiscal years, HCW Biologics's depreciation and amortization increased from $572,868 to $1.0M, a change of $468,903. The latest reported quarter, Q2 2026, shows $127,095.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HCW Biologics source filings ↗